Akt-Activated Endothelium Constitutes the Niche for Residual Disease and Resistance to Bevacizumab in Ovarian Cancer
Guerrouahen, B. S., Pasquier, J., Kaoud, N. A., Maleki, M., Beauchamp, M.-C., Yasmeen, A., Ghiabi, P., Lis, R., Vidal, F., Saleh, A., Gotlieb, W. H., Rafii, S., Rafii, A.Volume:
13
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-13-1053
Date:
December, 2014
File:
PDF, 1.65 MB
english, 2014